汇川技术：接受博时基金等投资者调研

Group 1 - The core viewpoint of the article highlights that Huichuan Technology (SZ 300124) will conduct an investor survey from October 29 to November 7, 2025, with participation from the company's investor relations director Wang Xingran [1] - For the first half of 2025, Huichuan Technology's revenue composition shows that industrial automation accounts for 54.82%, while new energy contributes 45.18% [1] Group 2 - The article mentions that the chairman of Peking University Pharmaceutical, Xu Xiren, was investigated by the police prior to his arrest, indicating potential issues within the company [1] - Internal sources suggest that the group's assets have been disposed of by Xu, leading to unclear whereabouts of significant funds [1]